In the following tables, normal reference values for commonly requested laboratory tests are listed in traditional units and in SI units. The tables are a guideline only. Values are method dependent and “normal values” may vary between laboratories.
| Blood, Plasma or Serum | ||||||||||||||||||||||||||
| Determination | Reference Value | |||||||||||||||||||||||||
| Conventional units | SI units | |||||||||||||||||||||||||
| Ammonia (NH3) - diffusion | 20–120 mcg/dl | 12–70 mcmol/L | ||||||||||||||||||||||||
| Ammonia Nitrogen | 15–45 µg/dl | 11–32 µmol/L | ||||||||||||||||||||||||
| Amylase | 35–118 IU/L | 0.58–1.97 mckat/L | ||||||||||||||||||||||||
| Anion gap (Na+-[Cl - + HCO3-]) (P) | 7–16 mEq/L | 7–16 mmol/L | ||||||||||||||||||||||||
| Antithrombin III (AT III) | 80–120 U/dl | 800–1200 U/L | ||||||||||||||||||||||||
|
21–28 mEq/L 22–29 mEq/L |
21–28 mmol/L 22–29 mmol/L |
||||||||||||||||||||||||
| Bilirubin: Conjugated (direct) Total | £ 0.2 mg/dl0.1–1 mg/dl | £ 4 mcmol/L2–18 mcmol/L | ||||||||||||||||||||||||
| Calcitonin | < 100 pg/ml | < 100 ng/L | ||||||||||||||||||||||||
|
8.6–10.3 mg/dl 4.4–5.1 mg/dl |
2.2–2.74 mmol/L 1–1.3 mmol/L |
||||||||||||||||||||||||
| Carbon dioxide content (plasma) | 21–32 mmol/L | 21–32 mmol/L | ||||||||||||||||||||||||
| Carcinoembryonic antigen | < 3 ng/ml | < 3 mcg/L | ||||||||||||||||||||||||
| Chloride | 95–110 mEq/L | 95–110 mmol/L | ||||||||||||||||||||||||
| Coagulation screen: Bleeding time Prothrombin time Partial thromboplastin time (activated) Protein C Protein S |
3–9.5 min 10–13 sec 22–37 sec 0.7–1.4 µ/ml 0.7–1.4 µ/ml |
180–570 sec 10–13 sec 22–37 sec 700–1400 U/ml 700–1400 U/ml |
||||||||||||||||||||||||
| Copper, total | 70–160 mcg/dl | 11–25 mcmol/L | ||||||||||||||||||||||||
| Corticotropin (ACTH adrenocorticotropic hormone) - 0800 hr | < 60 pg/ml | < 13.2 pmol/L | ||||||||||||||||||||||||
|
5–30 mcg/dl 2–15 mcg/dl £ 50% of 0800 hr |
138–810 nmol/L 50–410 nmol/L £ 50% of 0800 hr |
||||||||||||||||||||||||
|
20–170 IU/L 30–220 IU/L |
0.33–2.83 mckat/L 0.5–3.67 mckat/L |
||||||||||||||||||||||||
| Creatinine kinase isoenzymes, MB fraction | 0–12 IU/L | 0–0.2 mckat/L | ||||||||||||||||||||||||
| Creatinine | 0.5–1.7 mg/dl | 44–150 mcmol/L | ||||||||||||||||||||||||
| Fibrinogen (coagulation factor I) | 150–360 mg/dl | 1.5–3.6 g/L | ||||||||||||||||||||||||
| Follicle-stimulating hormone (FSH): Female Midcycle Male |
2–13 mlU/ml 5–22 mlU/ml 1–8 mlU/ml |
2–13 IU/L 5–22 IU/L 1–8 IU/L |
||||||||||||||||||||||||
| Glucose, fasting | 65–115 mg/dl | 3.6–6.3 mmol/L | ||||||||||||||||||||||||
| Glucose Tolerance Test (Oral)
Fasting |
|
|
||||||||||||||||||||||||
| (g) -Glutamyltransferase (GGT): Male Female |
9–50 units/L 8–40 units/L |
9–50 units/L 8–40 units/L |
||||||||||||||||||||||||
| Haptoglobin | 44–303 mg/dl | 0.44–3.03 g/L | ||||||||||||||||||||||||
| Determination | Reference Value | |||||||||||||||||||||||||
| Conventional units | SI units | |||||||||||||||||||||||||
| Hematologic tests: Fibrinogen Hematocrit (Hct), female male Hemoglobin A 1C Hemoglobin (Hb), female male Leukocyte count (WBC) Erythrocyte count (RBC), female male Mean corpuscular volume (MCV) Mean corpuscular hemoglobin (MCH) Mean corpuscular hemoglobin concentrate (MCHC) Erythrocyte sedimentation rate (sedrate, ESR) |
200–400 mg/dl 36%-44.6% 40.7%-50.3% 5.3%-7.5% of total Hgb 12.1–15.3 g/dl 13.8–17.5 g/dl 3800–9800/mcl 3.5–5 x 106/mcl 4.3–5.9 x 106/mcl 80–97.6 mcm3 27–33 pg/cell 33–36 g/dl £30 mm/hr |
2–4 g/L 0.36–0.446 fraction of 1 0.4–0.503 fraction of 1 0.053–0.075 121–153 g/L 138–175 g/L 3.8–9.8 x 109/L 3.5–5 x 1012/L 4.3–5.9 x 1012/L 80–97.6 fl 1.66–2.09 fmol/cell 20.3–22 mmol/L £ 30 mm/hr |
||||||||||||||||||||||||
| Erythrocyte enzymes: Glucose-6 -phosphate dehydrognase (G-6-PD) Ferritin Folic acid: normal Platelet count Reticulocytes Vitamin B12 |
250–5000 units/106 cells
10–383 ng/ml |
250–5000 mcunits/cell
23–862 pmol/L |
||||||||||||||||||||||||
|
30–160 mcg/dl 45–160 mcg/dl |
5.4–31.3 mcmol/L 8.1–31.3 mcmol/L |
||||||||||||||||||||||||
| Iron binding capacity | 220–420 mcg/dl | 39.4–75.2 mcmol/L | ||||||||||||||||||||||||
| Isocitrate dehydrogenase | 1.2–7 units/L | 1.2–7 units/L | ||||||||||||||||||||||||
| Isoenzymes Fraction 1 Fraction 2 Fraction 3 Fraction 4 Fraction 5 |
14%-26% of total 29%-39% of total 20%-26% of total 8%-16% of total 6%-16% of total |
0.14–0.26 fraction of total 0.29–0.39 fraction of total 0.20–0.26 fraction of total 0.08–0.16 fraction of total 0.06–0.16 fraction of total |
||||||||||||||||||||||||
| Lactate dehydrogenase | 100–250 IU/L | 1.67–4.17 mckat/L | ||||||||||||||||||||||||
| Lactic acid (lactate) | 6–19 mg/dl | 0.7–2.1 mmol/L | ||||||||||||||||||||||||
| Lead | £ 50 mcg/dl | £ 2.41 mcmol/L | ||||||||||||||||||||||||
| Lipase | 10–150 units/L | 10–150 units/L | ||||||||||||||||||||||||
| Lipids: Total Cholesterol Desirable Borderline-high High LDL Desirable Borderline-high High HDL (low) Triglycerides Desirable Borderline-high High Very high |
< 200 mg/dl < 130 mg/dl < 200 mg/dl |
< 5.2 mmol/L < 3.36 mmol/L < 2.26 mmol/L |
||||||||||||||||||||||||
| Magnesium | 1.3–2.2 mEq/L | 0.65–1.1 mmol/L | ||||||||||||||||||||||||
| Osmolality | 280–300 mOsm/kg | 280–300 mmol/kg | ||||||||||||||||||||||||
| Oxygen saturation (arterial) | 94%-100% | 0.94 - fraction of 1 | ||||||||||||||||||||||||
| PCO2, arterial | 35–45 mm Hg | 4.7–6 kPa | ||||||||||||||||||||||||
| pH, arterial | 7.35–7.45 | 7.35–7.45 | ||||||||||||||||||||||||
| Determination | Reference Value | |||||||||||||||||||||||||
| Conventional units | SI units | |||||||||||||||||||||||||
| PO2, arterial: Breathing room air1 On 100% O2 |
80–105 mm Hg > 500 mm Hg |
10.6–14 kPa | ||||||||||||||||||||||||
| Phosphatase (acid), total at 37°C | 0.13–0.63 IU/L | 2.2–10.5 IU/L or 2.2–10.5 mckat/L |
||||||||||||||||||||||||
| Phosphatase alkaline2 | 20–130 IU/L | 20–130 IU/L or 0.33–2.17 mckat/L |
||||||||||||||||||||||||
| Phosphorus, inorganic,3 (phosphate) | 2.5–5 mg/dl | 0.8–1.6 mmol/L | ||||||||||||||||||||||||
| Potassium | 3.5–5 mEq/L | 3.5–5 mmol/L | ||||||||||||||||||||||||
| Progesterone Female Follicular phase Luteal phase Male |
0.1–1.5 ng/ml 0.1–1.5 ng/ml 2.5–28 ng/ml < 0.5 ng/ml |
0.32–4.8 nmol/L 0.32–4.8 nmol/L 8–89 nmol/L < 1.6 nmol/L |
||||||||||||||||||||||||
| Prolactin | 1.4–24.2 ng/ml | 1.4–24.2 mcg/L | ||||||||||||||||||||||||
| Prostate specific antigen Protein: Total Albumin Globulin |
0–4 ng/ml 6–8 g/dl 3.6–5 g/dl 2.3–3.5 g/dl |
0–4 ng/ml 60–80 g/L 36–50 g/L 23–35 g/L |
||||||||||||||||||||||||
| Rheumatoid factor | < 60 IU/ml | < 60 kIU/L | ||||||||||||||||||||||||
| Sodium | 135–147 mEq/L | 135–147 mmol/L | ||||||||||||||||||||||||
| Testosterone: Female Male |
6–86 ng/dl 270–1070 ng/dl |
0.21–3 nmol/L 9.3–37 nmol/L |
||||||||||||||||||||||||
| Thyroid Hormone Function Tests: Thyroid-stimulating hormone (TSH) Thyroxine-binding globulin capacity Total triiodothyronine (T3) Total thyroxine by RIA (T4) T3 resin uptake |
0.35–6.2 mcU/ml 10–26 mcg/dl 75–220 ng/dl 4–11 mcg/dl 25%-38% |
0.35–6.2 mU/L 100–260 mcg/L 1.2–3.4 nmol/L 51–142 nmol/L 0.25–0.38 fraction of 1 |
||||||||||||||||||||||||
| Transaminase, AST (aspartate aminotransferase, SGOT) | 11–47 IU/L | 0.18–0.78 mckat/L | ||||||||||||||||||||||||
| Transaminase, ALT (alanine aminotransferase, SGPT) | 7–53 IU/L | 0.12–0.88 mckat/L | ||||||||||||||||||||||||
| Transferrin | 220–400 mg/dL | 2.20–4.00 g/L | ||||||||||||||||||||||||
| Urea nitrogen (BUN) | 8–25 mg/dl | 2.9–8.9 mmol/L | ||||||||||||||||||||||||
| Uric acid | 3–8 mg/dl | 179–476 mcmol/L | ||||||||||||||||||||||||
| Vitamin A (retinol) | 15–60 mcg/dl | 0.52–2.09 mcmol/L | ||||||||||||||||||||||||
| Zinc | 50–150 mcg/dl | 7.7–23 mcmol/L | ||||||||||||||||||||||||
1 Age dependent
2 Infants and adolescents up to 104 U/L
3 Infants in the first year up to 6 mg/dl
| Urine | ||
| Determination | Reference Value | |
| Conventional units | SI units | |
| Calcium1 | 50–250 mcg/day | 1.25–6.25 mmol/day |
| Catecholamines: Epinephrine Norepinephrine |
< 20 mcg/day < 100 mcg/day |
< 109 nmol/day < 590 nmol/day |
| Catecholamines, 24-hr | < 110 µg | < 650 nmol |
| Copper1 | 15–60 mcg/day | 0.24–0.95 mcmol/day |
| Creatinine: Child Adolescent Female Male |
8–22 mg/kg 8–30 mg/kg 0.6–1.5 g/day 0.8–1.8 g/day |
71–195 µmol/kg 71–265 µmol/kg 5.3–13.3 mmol/day 7.1–15.9 mmol/day |
| pH | 4.5–8 | 4.5–8 |
| Phosphate1 | 0.9–1.3 g/day | 29–42 mmol/day |
| Potassium1 | 25–100 mEq/day | 25–100 mmol/day |
| Protein Total At rest |
1–14 mg/dL 50–80 mg/day |
10–140 mg/L 50–80 mg/day |
| Protein, quantitative | < 150 mg/day | < 0.15 g/day |
| Sodium1 | 100–250 mEq/day | 100–250 mmol/day |
| Specific gravity, random | 1.002–1.030 | 1.002–1.030 |
| Uric acid, 24-hr | 250–750 mg | 1.48–4.43 mmol |
| Drug Levels* | |||
| Drug Determination | Reference Value | ||
| Conventional units | SI units | ||
| Aminoglycosides | Amikacin (trough) (peak) |
1–8 mcg/ml 1.7–13.7 mcmol/L |
20–30 mcg/ml 34–51 mcmol/L |
| Gentamicin (trough) (peak) |
0.5–2 mcg/ml 6–10 mcg/ml |
1–4.2 mcmol/L 12.5–20.9 mcmol/L |
|
| Kanamycin (trough) (peak) |
5–10 mcg/ml 20–25 mcg/ml |
nd1 nd |
|
| Netilimicin (trough) (peak) |
0.5–2 mcg/ml 6–10 mcg/ml |
nd nd |
|
| Streptomycin (trough) (peak) |
< 5 mcg/ml 5–20 mcg/ml |
nd nd |
|
| Tobramycin (trough) (peak) |
0.5–2 mcg/ml 5–20 mcg/ml |
1.1–4.3 mcmol/L 12.8–21.8 mcmol/L |
|
| Drug Determination | Reference Value | ||
| Conventional units | SI units | ||
| Antiarrhythmics | Amiodarone | 0.5–2.5 mcg/ml | 1.5–4 mcmol/L |
| Bretylium | 0.5–1.5 mcg/ml | nd | |
| Digitoxin | 9–25 mcg/L | 11.8–32.8 nmol/L | |
| Digoxin | 0.8–2 ng/ml | 0.9–2.5 nmol/L | |
| Disopyramide | 2–8 mcg/ml | 6–18 mcmol/L | |
| Flecainide | 0.2–1 mcg/ml | nd | |
| Lidocaine | 1.5–6 mcg/ml | 4.5–21.5 mcmol/L | |
| Mexiletine | 0.5–2 mcg/ml | nd | |
| Procainamide | 4–8 mcg/ml | 17–34 mcmol/ml | |
| Propranolol | 50–200 ng/ml | 190–770 nmol/L | |
| Quinidine | 2–6 mcg/ml | 4.6–9.2 mcmol/L | |
| Tocainide | 4–10 mcg/ml | nd | |
| Verapamil | 0.08–0.3 mcg/ml | nd | |
| Anticonvulsants | Carbamazepine | 4–12 mcg/ml | 17–51 mcmol/L |
| Phenobarbital | 10–40 mcg/ml | 43–172 mcmol/L | |
| Phenytoin | 10–20 mcg/ml | 40–80 mcmol/L | |
| Primidone | 4–12 mcg/ml | 18–55 mcmol/L | |
| Valproic Acid | 40–100 mcg/ml | 280–700 mcmol/L | |
| Antidepressants | Amitriptyline | 110–250 ng/ml2 | 500–900 nmol/L |
| Amoxapine | 200–500 ng/ml | nd | |
| Bupropion | 25–100 ng/ml | nd | |
| Clomipramine | 80–100 ng/ml | nd | |
| Desipramine | 115–300 ng/ml | nd | |
| Doxepin | 110–250 ng/ml2 | nd | |
| Imipramine | 225–350 ng/ml2 | nd | |
| Maprotiline | 200–300 ng/ml | nd | |
| Nortriptyline | 50–150 ng/ml | nd | |
| Protriptyline | 70–250 ng/ml | nd | |
| Trazodone | 800–1600 ng/ml | nd | |
| Antipsychotics | Chlorpromazine | 50–300 ng/ml | 150–950 nmol/L |
| Fluphenazine | 0.13–2.8 ng/ml | nd | |
| Haloperidol | 5–20 ng/ml | nd | |
| Perphenazine | 0.8–1.2 ng/ml | nd | |
| Thiothixene | 2–57 ng/ml | nd | |
| Drug Determination | Reference Value | ||
| Conventional units | SI units | ||
| Miscellaneous | Amantadine Amrinone |
300 ng/ml 3.7 mcg/ml |
nd nd |
| Chloramphenicol | 10–20 mcg/ml | 31–62 mcmol/L | |
| Cyclosporine3 | 250–800 ng/ml (whole blood, RIA) 50–300 ng/ml (plasma, RIA) |
nd nd |
|
| Ethanol4 | 0 mg/dl | 0 mmol/L | |
| Hydralazine | 100 ng/ml | nd | |
| Lithium | 0.6–1.2 mEq/L | 0.6–1.2 mmol/L | |
| Salicylate | 100–300 mg/L | 724–2172 mcmol/L | |
| Sulfonamide | 5–15 mg/dl | nd | |
| Terbutaline | 0.5–4.1 ng/ml | nd | |
| Theophylline | 10–20 mcg/ml | 55–110 mcmol/L | |
| Vancomycin (trough) (peak) |
5–15 ng/ml 20–40 mcg/ml |
nd nd |
|
* The values given are generally accepted as desirable for treatment without toxicity for most patients. However, exceptions are not uncommon.
1 nd = No data available.
2 Parent drug plus N-desmethyl metabolite.
3 24–hour trough values.
4 Toxic: 50–100 mg/dl (10.9–21.7 mmol/L).
The following table is adopted from the Sixth Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure, National Institutes of Health.
| Classification of Blood Pressure* | |||
| Category | Reference value | ||
| Systolic (mm Hg) | Diastolic (mm Hg) | ||
| Optimal1 | < 120 | and | < 80 |
| Normal | < 130 | and | < 85 |
| High-normal | 130–139 | or | 85–89 |
| Hypertension2 Stage 1 Stage 2 Stage 3 |
140–159 160–179 ³ 180 |
or or or |
90–99 100–109 ³ 110 |
* For adults age 18 and older who are not taking antihypertensive drugs and not acutely ill. When systolic and diastolic blood pressures fall into different categories, the higher category should be selected to classify the individual’s blood pressure status. In addition to classifying stages of hypertension on the basis of average blood pressure levels, clinicians should specify presence or absence of target organ disease and additional risk factors.
1 Optimal blood pressure with respect to cardiovascular risk is below 120/88 m Hg. However, unusually low readings should be evaluated for clinical significance.
2 Based on the average of two or more readings taken at each of two or more visits after an initial screening.
Popularity: 11% [?]
RSS feed for comments on this post · TrackBack URI
Leave a reply